Department of First Chemotherapy, Guangxi Medical University Cancer Hospital, Nanning, China.
Hepatobiliary Surgery Department, Guangxi Medical University Cancer Hospital, Nanning, China.
Pathol Oncol Res. 2022 Jun 17;28:1610506. doi: 10.3389/pore.2022.1610506. eCollection 2022.
Hepatocellular carcinoma is the most common type of primary liver cancer, and it is associated with poor prognosis. It often fails to respond to immunotherapy, highlighting the need to identify genes that are associated with the tumor microenvironment and may be good therapeutic targets. We and others have shown that the Holliday cross-recognition protein can promote the proliferation, migration, and invasion by hepatocellular carcinoma cells, and that overexpression is associated with poor survival. Here we explored the potential relationship between and the tumor microenvironment in hepatocellular carcinoma. We used the Immuno-Oncology-Biological-Research (IOBR) software package to analyze the potential roles of in the tumor microenvironment. Using single-cell RNA sequencing data, we identified the cell clusters expressing abundant , then linked some of these clusters to certain bioprocesses using Gene Set Enrichment Analysis (GSEA). We validated the differential expression of in tumor-infiltrating CD8 T cells, sorted by flow cytometry into populations based on the expression level of PD-1. We used weighted gene co-expression network analysis (WGCNA) to identify immunity-related genes whose expression strongly correlated with that of . The function of these genes was validated based on enrichment in Gene Ontology (GO) terms, and they were used to establish a prognosis prediction model. IOBR analysis suggested that is significantly related to the immunosuppressive tumor microenvironment and was significantly related to T cells, dendritic cells, and B cells. Based on single-cell RNA sequencing, was strongly expressed in T cells, erythrocytes, and B cells from normal liver tissues, as well as in CD8 T cells, dendritic cells, and one cluster of hepatocytes in hepatocellular carcinoma tissues. Malignant hepatocytes strongly expressing were associated with the downregulation of immune bioprocesses. expression was significantly higher in CD8 T cells strongly expressing PD-1 than in those expressing no or intermediate levels of PD1. WGCNA identified two module eigengenes (comprising 397 and 84 genes) related to the tumor microenvironment. We identified 24 hub genes and confirmed that they were related to immune regulation. A prognostic risk score model based on expression of , , , and showed moderate ability to predict survival. is associated with tumor-infiltrating immune cells, immune checkpoints, and immune suppression in hepatocellular carcinoma. -related genes involved in immune responses may be useful for predicting patient prognosis.
肝细胞癌是最常见的原发性肝癌类型,其预后较差。它通常对免疫疗法无反应,这凸显了需要识别与肿瘤微环境相关且可能成为良好治疗靶点的基因。我们和其他人已经表明,Holliday 交叉识别蛋白可以促进肝癌细胞的增殖、迁移和侵袭,并且 过表达与生存不良相关。在这里,我们探讨了 与肝细胞癌肿瘤微环境之间的潜在关系。我们使用免疫肿瘤生物学研究(IOBR)软件包分析 在肿瘤微环境中的潜在作用。使用单细胞 RNA 测序数据,我们鉴定了表达丰富 的细胞簇,然后使用基因集富集分析(GSEA)将其中一些簇与某些生物过程联系起来。我们通过流式细胞术根据 PD-1 的表达水平将肿瘤浸润性 CD8 T 细胞分选到不同群体中,验证了 在肿瘤浸润性 CD8 T 细胞中的差异表达。我们使用加权基因共表达网络分析(WGCNA)鉴定了表达与 强相关的免疫相关基因。根据基因本体论(GO)术语的富集验证了这些基因的功能,并将其用于建立预后预测模型。IOBR 分析表明, 与免疫抑制性肿瘤微环境显著相关,与 T 细胞、树突状细胞和 B 细胞显著相关。基于单细胞 RNA 测序, 在正常肝组织中的 T 细胞、红细胞和 B 细胞,以及肝癌组织中的 CD8 T 细胞、树突状细胞和一个肝细胞簇中强烈表达。强烈表达 的恶性肝细胞与免疫生物过程的下调相关。 在强烈表达 PD-1 的 CD8 T 细胞中表达显著高于不表达或表达中等水平 PD1 的 CD8 T 细胞中表达。WGCNA 鉴定了两个与肿瘤微环境相关的模块特征基因(包含 397 和 84 个基因)。我们鉴定了 24 个枢纽基因,并证实它们与免疫调节有关。基于 、 、 和 表达的预后风险评分模型显示出中等的生存预测能力。 在肝细胞癌中与肿瘤浸润免疫细胞、免疫检查点和免疫抑制有关。与免疫反应相关的 - 相关基因可能有助于预测患者的预后。